Why oncology investors are watching Cogent Biosciences, Inc.’s PEAK data closely
Why investors are closely watching Cogent Biosciences’ PEAK data and what bezuclastinib could mean for valuation, revenue growth, and oncology market sentiment.
Can Mobix Labs, Inc.’s mission-critical F-22 systems win drive long-term defense market upside? (Nasdaq: MOBX)
Can Mobix Labs, Inc.’s F-22 systems win unlock long-term defense upside? Read what this means for Nasdaq: MOBX, investor sentiment, and aerospace growth.
How Hyperscale Data, Inc.’s settlement-driven cash influx may reset the market’s liquidity debate (NYSE American: GPUS)
Find out how Hyperscale Data, Inc.’s $26.6 million settlement cash influx could reshape liquidity, funding flexibility, and investor sentiment today.
Can Plug Power Inc.’s 275 MW Hy2gen award strengthen its position in North America’s hydrogen infrastructure market? (NASDAQ: PLUG)
Plug Power Inc.’s 275 MW Québec hydrogen win could reshape mining chemical decarbonization. Find out what it means for NASDAQ: PLUG and the sector.
What the CHMP’s positive view on lomitapide reveals about the evolving HoFH treatment landscape in children
See how Chiesi Group’s paediatric lomitapide expansion could reshape HoFH treatment access, payer dynamics, and rare disease growth across Europe.
What clinicians may watch next in Evaxion A/S’s artificial intelligence vaccine platform
What clinicians and investors may watch next in Evaxion A/S’s AI vaccine platform as polio and CMV programs test the commercial case for TechBio innovation.
Why QXO, Inc.’s $2.25bn Kodiak acquisition could reshape the building materials distribution landscape
Discover how QXO, Inc.’s $2.25 billion Kodiak acquisition could reshape building materials distribution and accelerate its long-term growth strategy.
Can Crane NXT Co. turn Antares Vision into a scalable detection and traceability platform for regulated industries? (NYSE: CXT)
Find out how Crane NXT Co.’s Antares Vision acquisition could reshape its growth strategy in life sciences and food traceability markets. Read more.
Can Arclin turn Kevlar and Nomex into a scalable advanced materials growth engine after the $1.8bn DuPont acquisition?
Find out whether Arclin can turn Kevlar and Nomex into a scalable advanced materials growth engine after its $1.8 billion DuPont acquisition.
Can Ondas Holdings Inc. turn stratospheric sensing into a scalable ISR growth engine after the World View acquisition? (Nasdaq: ONDS)
Find out what the World View acquisition means for Ondas Holdings Inc.’s defense platform strategy, contract pipeline, and future revenue visibility.